Purdue Pharma “misrepresented” impact of OxyContin, former sales rep says

June 21, 2018

Purdue Pharma, the maker of OxyContin, admitted to falsley claiming the drug was less addictive than other opioids. But a former salesperson says the company’s questionable practices did not end there. CBS News correspondent Tony Dokoupil reports.

Read Full Article

September 29, 2021
Overuse of social media can impact mental health
September 10, 2021
Black Opioid Overdose Deaths Are Increasing Faster Than Whites, Study Finds
September 7, 2021
Man pushing beverage cart to NYC to honor 9/11 heroes
August 26, 2021
California governor, lawmakers want to pay addicts to get sober
August 25, 2021
In ‘Dopamine Nation,’ Overabundance Keeps Us Craving More
August 21, 2021
Many ERs Fail People Who Struggle With Addiction. These New Approaches Might Help